A Randomized Open-Label Clinical Trial of Lipid-Lowering Therapy in Psoriasis to Reduce Vascular Endothelial Inflammation.

Michael S Garshick Kamelia Drenkova Tessa J Barrett Florencia Schlamp Edward A Fisher Stuart Katz Sanja Jelic Andrea L Neimann Jose U Scher James Krueger Jeffrey S Berger

J Invest Dermatol

Center for the Prevention of Cardiovascular Disease, Department of Medicine, NYU Langone Health, New York, New York, USA; Leon H. Charney Division of Cardiology, Department of Medicine, NYU Langone Health, New York, New York, USA; Cardiovascular Research Center, NYU Langone Health, New York, New York, USA; Division of Hematology & Medical Oncology, Department of Medicine, NYU Langone Health, New York, New York, USA; Division of Vascular & Endovascular Surgery, Department of Surgery, NYU Langone Health, New York, New York, USA.

Published: June 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893130	PMC
http://dx.doi.org/10.1016/j.jid.2021.07.190	DOI Listing

Publication Analysis

Top Keywords

randomized open-label

open-label clinical

clinical trial

trial lipid-lowering

lipid-lowering therapy

therapy psoriasis

psoriasis reduce

reduce vascular

vascular endothelial

endothelial inflammation

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!